SUBSCRIBE
SUBSCRIBE

Nick Paul Taylor

Nick is a freelance writer who has been reporting on the global life sciences industry since 2008. With a BSc in biology, Nick writes about the science and business of biopharma and medtech for numerous healthcare publications. He can be reached at nick.paul.taylor@gmail.com or on LinkedIn.

High Quality background with Two Flags of South Korea and USA
Manufacturing
Gilead inks $140M API supply deal, tightening ties to Korean manufacturer
The agreement is the largest in a series of deals that Gilead Sciences has penned with Korea’s Yuhan.
May 22, 2026
 · 
1 min read
 · 
Nick Paul Taylor
too many different pill of various blisters with different pills Medicines storage at home concept Medication storing. A pile of medicine in blister packs. Pharmaceutical blister packs.
Manufacturing
Roche licensing pact clears generic drugmakers to manufacture antiviral flu drug
By partnering with a UN-backed body, Roche has enabled companies to make the medicine for supply in 129 countries.
May 21, 2026
 · 
2 min read
 · 
Nick Paul Taylor
Email envelope with warning sign on white background
Manufacturing
FDA sends warning letter after Chinese supplier breaks GLP-1 import restrictions
While the manufacturer is on the list of authorized GLP-1 importers, FDA inspectors found the company relabeled APIs from another site in a potential attempt to “circumvent safeguards.”
May 20, 2026
 · 
2 min read
 · 
Nick Paul Taylor
Digital isometric background red warning alert icon and decreasing stock market graph, economic crisis, financial risk, and market crash.
Vaccines
Moderna’s stock rides hantavirus fears as spotlight returns to infectious disease platform
While the pathogen appears unlikely to trigger a pandemic, analysts see potential for Moderna to build goodwill amid a period of political pressure on vaccine manufacturers.
May 20, 2026
 · 
4 min read
 · 
Nick Paul Taylor
Businessman finds himself difficult to make decision because of too many directions or choices to choose. Cute character vector illustration, outline, thin line art, hand drawn sketch, black and white ink style.
Antibody-drug conjugate (ADC)
Daiichi emerges from bruising 2 years with vision for cracking cancer’s big leagues
Clinical trial setbacks have limited the near-term opportunities for some of Daiichi Sankyo’s ADCs but the drug developer is betting near-term readouts will catapult it into the top tier of oncology companies in the coming years.
May 20, 2026
 · 
4 min read
 · 
Nick Paul Taylor
Vector illustration. Product recall.
Manufacturing
Sun Pharma recalls cancer drug after finding glass particles in some vials
A batch of a chemotherapy product made at a Sun facility with a history of quality and compliance issues is being withdrawn from the U.S. market.
May 15, 2026
 · 
2 min read
 · 
Nick Paul Taylor
Smart industry and digital manufacturing concept with glowing polygonal factory connected to circuit board on dark blue background. Futuristic low poly style, abstract vector illustration.
Manufacturing
Bora inks $122.5M takeover of MacroGenics facility to further US expansion
MacroGenics is selling the manufacturing plant to Bora, a Taiwan-based CDMO, to raise cash to support the progress of its drug development pipeline.
May 13, 2026
 · 
2 min read
 · 
Nick Paul Taylor
US (UNITED STATES) VS EU (EUROPEAN UNION) - Trade war and politics conflicts concept - Concept with flags painted on cracked wall
Mergers & acquisitions
Mid-sized European drugmakers are snapping up US biotechs. Will the surge continue?
European pharma companies splashed billions of dollars into the U.S. biopharma sector in a matter of days, but there are differing views on whether the activity represents the rise of a new buyer class or a quirk of timing.
May 13, 2026
 · 
4 min read
 · 
Nick Paul Taylor
Rainy season, heavy rain, Rain drops background, Nature rainfall with storm clouds
Earnings
Daiichi takes $850M charge, axes facility investment as ADC demand forecast falls
While Daiichi Sankyo brought in $13.4 billion in 2025, setbacks forced the company to update its antibody-drug conjugate forecast, pushing demand below the minimum supply agreed upon with CMOs and prompting the cancellation of an in-house investment.
May 11, 2026
 · 
2 min read
 · 
Nick Paul Taylor
Composite photo collage of hand hold magnifier glass research examine secret object question mark secret isolated on painted background.
Manufacturing
FDA pilots AI-informed one-day facility inspections
Implemented as part of a broader initiative to make more targeted and efficient use of inspection resources, the pilot program will use artificial intelligence to enable shorter, focused screenings to complement standard FDA inspections.
May 7, 2026
 · 
2 min read
 · 
Nick Paul Taylor
Community expansion. Collaboration, of new members. Cooperate on project development. Find like-minded people, join the team. Spread influence and power.
Manufacturing
Amgen, Sanofi commit nearly $600M to North American expansions
Sanofi’s investment will support a Canadian site’s efforts to apply AI to drug production, while Amgen has unveiled the second expansion of its Puerto Rico plant in quick succession.
May 6, 2026
 · 
2 min read
 · 
Nick Paul Taylor
Factory closed with disappointed worker doodle cartoon illustration. Industrial shutdown. Layoff in manufacturing plant closure 2D flat character isolated on white. Doodleart hand-drawn drawing
Layoffs
BioNTech moves to close multiple manufacturing plants, affecting 1,860 jobs
The action affects BioNTech sites in Germany and Singapore, where the company expects to have excess capacity.
May 5, 2026
 · 
2 min read
 · 
Nick Paul Taylor
pills Medicine tablet in blister pack on a yellow background
Manufacturing
Sertraline manufacturer recalls antidepressant batch after UK packaging mix-up
A subsidiary of Indian drugmaker Hetero Group mistakenly packaged two types of antidepressants in packs of sertraline, potentially posing risks to patients.
May 5, 2026
 · 
2 min read
 · 
Nick Paul Taylor
pharmaceutical industry, medicine pills are filling in the bottle on production line machine conveyor at the medical factory. selective focus.
Manufacturing
PCI adds US sterile fill/finish capabilities through $1B global expansion drive
Amid disruption to the outsourced fill/finish market, PCI is investing $100 million to more than double the capacity to fill ready-to-use prefilled syringes and cartridges at its San Diego campus.
May 4, 2026
 · 
2 min read
 · 
Nick Paul Taylor
A surreal concept of a regular aluminium ladder pushing through a fluffy cloud on a peach sky background - 3D render
Obesity
Obesity ends oncology’s long reign as top contributor to biopharma pipeline value
In its latest biopharma pipeline report, Deloitte warned that the growing importance of a small pool of potential mega-blockbusters raises the risk of “significant value destruction from a single program failure.”
May 4, 2026
 · 
2 min read
 · 
Nick Paul Taylor
Load More